Cargando…

A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab

We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history of long-standing retinal detachment in his right eye after the irrigation and aspiration of a congenital cataract, presented with a clinical picture of elevated intraocular pressure and o...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jongseok, Lee, Hoyoung, Kim, Young Kook, Chae, Jeong Don, Lee, Hyun Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178775/
https://www.ncbi.nlm.nih.gov/pubmed/21976948
http://dx.doi.org/10.3341/kjo.2011.25.5.362
_version_ 1782212434615861248
author Park, Jongseok
Lee, Hoyoung
Kim, Young Kook
Chae, Jeong Don
Lee, Hyun Joo
author_facet Park, Jongseok
Lee, Hoyoung
Kim, Young Kook
Chae, Jeong Don
Lee, Hyun Joo
author_sort Park, Jongseok
collection PubMed
description We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history of long-standing retinal detachment in his right eye after the irrigation and aspiration of a congenital cataract, presented with a clinical picture of elevated intraocular pressure and ocular pain. Upon slit-lamp examination, we found a ciliary injection and a pseudohypopyon of polychromatic crystals. Gonioscopic examination revealed a large amount of crystals deposited on the trabecular meshwork and mild rubeosis iridis, but the neovascularization of the angle could not be clearly confirmed due to the presence of so many crystals. Pars plana vitrectomy was performed to remove clusters of crystals and bevacizumab was injected intravitreally to treat iris neovascularization. Aqueous aspirate was examined by light microscopy and the typical highly refringent cholesterol crystals were identified. Intraocular pressure returned to a normal level after the bevacizumab injection, although severe cholesterosis was still evident in the anterior chamber. To our knowledge, this would be the first Korean case of cholesterosis bulbi combined with chronic retinal detachment and presumed neovascular glaucoma, which was treated by pars plana vitrectomy and intravitreal bevacizumab injection.
format Online
Article
Text
id pubmed-3178775
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Korean Ophthalmological Society
record_format MEDLINE/PubMed
spelling pubmed-31787752011-10-05 A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab Park, Jongseok Lee, Hoyoung Kim, Young Kook Chae, Jeong Don Lee, Hyun Joo Korean J Ophthalmol Case Report We report on a case of cholesterosis bulbi concurrent with secondary glaucoma. A 36-year-old man, with a history of long-standing retinal detachment in his right eye after the irrigation and aspiration of a congenital cataract, presented with a clinical picture of elevated intraocular pressure and ocular pain. Upon slit-lamp examination, we found a ciliary injection and a pseudohypopyon of polychromatic crystals. Gonioscopic examination revealed a large amount of crystals deposited on the trabecular meshwork and mild rubeosis iridis, but the neovascularization of the angle could not be clearly confirmed due to the presence of so many crystals. Pars plana vitrectomy was performed to remove clusters of crystals and bevacizumab was injected intravitreally to treat iris neovascularization. Aqueous aspirate was examined by light microscopy and the typical highly refringent cholesterol crystals were identified. Intraocular pressure returned to a normal level after the bevacizumab injection, although severe cholesterosis was still evident in the anterior chamber. To our knowledge, this would be the first Korean case of cholesterosis bulbi combined with chronic retinal detachment and presumed neovascular glaucoma, which was treated by pars plana vitrectomy and intravitreal bevacizumab injection. The Korean Ophthalmological Society 2011-10 2011-09-20 /pmc/articles/PMC3178775/ /pubmed/21976948 http://dx.doi.org/10.3341/kjo.2011.25.5.362 Text en © 2011 The Korean Ophthalmological Society http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Park, Jongseok
Lee, Hoyoung
Kim, Young Kook
Chae, Jeong Don
Lee, Hyun Joo
A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
title A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
title_full A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
title_fullStr A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
title_full_unstemmed A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
title_short A Case of Cholesterosis Bulbi with Secondary Glaucoma Treated by Vitrectomy and Intravitreal Bevacizumab
title_sort case of cholesterosis bulbi with secondary glaucoma treated by vitrectomy and intravitreal bevacizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178775/
https://www.ncbi.nlm.nih.gov/pubmed/21976948
http://dx.doi.org/10.3341/kjo.2011.25.5.362
work_keys_str_mv AT parkjongseok acaseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT leehoyoung acaseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT kimyoungkook acaseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT chaejeongdon acaseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT leehyunjoo acaseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT parkjongseok caseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT leehoyoung caseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT kimyoungkook caseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT chaejeongdon caseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab
AT leehyunjoo caseofcholesterosisbulbiwithsecondaryglaucomatreatedbyvitrectomyandintravitrealbevacizumab